Skip to Main Content

Paper Details

Circulating Tumor DNA as a Biomarker in Patients With Stage III and IV Wilms Tumor: Analysis From a Children's Oncology Group Trial, AREN0533.
Journal of Clinical Oncology
17
2022
Author NameAffiliation
Aaron R ThornerCenter for Cancer Genomics, Dana-Farber Cancer Institute
Elizabeth A Mullen
Brian D Crompton
Brian D CromptonBroad Institute of Harvard and MIT
  • 1 - 4

Datasets

Release 1.2